Pharmaniaga Bhd (XKLS:7081) EPS (Basic): RM0.06 (TTM As of Mar. 2026)


XKLS:7081 Pharmaniaga Bhd XKLS:7081
46 GF Score
Price RM1.18
GF Value RM0.76
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd EPS (Basic)?

Pharmaniaga Bhd XKLS:7081 -0.84% 46 EPS (Basic) is RM0.06 as of Mar. 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 46/100 and a GF Value™ of RM0.76 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Pharmaniaga Bhd's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was RM0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.06.

Pharmaniaga Bhd's EPS (Diluted) for the three months ended in Mar. 2026 was RM0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.06.

Pharmaniaga Bhd's EPS without NRI for the three months ended in Mar. 2026 was RM0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.06.

During the past 12 months, Pharmaniaga Bhd's average EPS without NRIGrowth Rate was -79.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Pharmaniaga Bhd's highest 3-Year average EPS without NRI Growth Rate was 68.20% per year. The lowest was -58.10% per year. And the median was -5.40% per year.

Pharmaniaga Bhd  (XKLS:7081) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pharmaniaga Bhd EPS (Basic) Related Terms

Pharmaniaga Bhd EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Pharmaniaga Bhd's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaniaga Bhd EPS (Basic) Chart

Pharmaniaga Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 -1.43 -0.17 0.27 0.07

Pharmaniaga Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.01 0.01 0.01 0.02
XKLS:7081
46GF Score
Pharmaniaga Bhd XKLS:7081
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaniaga Bhd EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pharmaniaga Bhd's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(48.51-0)/722.738
=0.07

Pharmaniaga Bhd's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(31.471-0)/1311.405
=0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of RM0.06 mean?
Pharmaniaga Bhd (XKLS:7081) has a EPS (Basic) of RM0.06 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Pharmaniaga Bhd and its competitors.
Is Pharmaniaga Bhd's EPS (Basic) too high?
Pharmaniaga Bhd's current EPS (Basic) is RM0.06. Overall, Pharmaniaga Bhd has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's EPS (Basic) compare to MCK and COR?
Pharmaniaga Bhd's EPS (Basic) of RM0.06 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Distribution company?
A good EPS (Basic) depends on the Medical Distribution industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current EPS (Basic) is RM0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.76, compared to a current price of RM1.18 — trading 55.3% above its estimated fair value. The current EPS (Basic) is RM0.06. Pharmaniaga Bhd's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current EPS (Basic) is RM0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.18 is trading 55.3% above its estimated GF Value™ of RM0.76. GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.

Key valuation signals for XKLS:7081:

  • EPS (Basic): RM0.06
  • GF Value™: RM0.76 vs. price of RM1.18 (55.3% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
46GF Score

Get the complete analysis for XKLS:7081

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.18
Price
RM0.76
GF Value